LUXEMBOURG, Nov. 14, 2013 /PRNewswire/ -- ConvaTec today announced that it will report its 2013 third quarter earnings on Tuesday, November 19, 2013. Ken Berger, CEO, and John Cannon, acting CFO, will host an analyst and investor call at 9:00 AM ET live via telephone.
To participate in the conference call within the U.S. and Canada, dial (877) 366-0267.
To participate in the conference call outside the U.S. and Canada, dial (760) 666-3086.
The conference ID is 10518914.
Participants should dial in 10 minutes prior to the start of the call. The Company's 2013 Third Quarter Report will be available on the Company's website prior to the call under the Investor Community at www.convateccorporate.com.
For more information, please contact firstname.lastname@example.org.
ConvaTec is a global medical products and technologies company, with leading market positions in ostomy care, wound therapeutics, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. For more information, please visit www.convatec.com.